PMC:7781431 / 581-829
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 37 | 100-106 | Chemical | denotes | lipids | MESH:D008055 |
| 38 | 124-132 | Chemical | denotes | lipoxins | MESH:D044045 |
| 39 | 134-143 | Chemical | denotes | resolvins | |
| 40 | 145-153 | Chemical | denotes | maresins | |
| 45 | 34-43 | Disease | denotes | mortality | MESH:D003643 |
| 46 | 232-244 | Disease | denotes | inflammation | MESH:D007249 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 45-245 | Sentence | denotes | Recent studies have demonstrated special pro-resolving lipids mediators (SPMs) lipoxins, resolvins, maresins, and protectins as potential therapeutic options for abnormal viral-triggered inflammation. |